Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse
- 7 December 2000
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 12 (3) , 231-238
- https://doi.org/10.1016/s0928-0987(00)00170-6
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonismSynapse, 1995
- Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatumNeurotoxicology and Teratology, 1995
- Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomographyAnnals of Neurology, 1992
- Effect of Unilateral Perinatal Hypoxic‐Ischemic Brain Injury in the Rat on Dopamine D1 and D2 Receptors and Uptake Sites: A Quantitative Autoradiographic StudyJournal of Neurochemistry, 1991
- 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particlesBiochemical and Biophysical Research Communications, 1990
- Effects of 1‐Methyl‐4‐Phenyl‐ 1,2,3,6‐Tetrahydropyridine and 1 ‐Methyl‐4‐Phenylpyridinium Ion on ATP Levels of Mouse Brain SynaptosomesJournal of Neurochemistry, 1990
- Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]racloprideNeuroscience Letters, 1986
- Dopamine D-1 receptors in the parkinsonian brainBrain Research, 1985
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983